Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil

Familial Cancer

Volumn 9, Issue 2, 2010, Pages 131-139

  Cossio, Silvia Liliana ^a,b,c   Koehler Santos, Patricia ^a,b   Pessini, Suzana Arenhart ^d,e   Mónego, Heleuza ^b   Edelweiss, Maria Isabel ^a,b   Meurer, Luise ^a,b   Errami, Abdellatif ^f   Coffa, Jordy ^f   Bock, Hugo ^a,b   Saraiva Pereira, Maria Luiza ^a   Ashton Prolla, Patricia ^c   Prolla, João Carlos ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Instituto Nacional de Genética Médica Populacional INAGEMP   (Brazil)

^d Faculdade Federal de Ciências Médicas de Porto Alegre   (Brazil)

^e UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^f MRC HOLLAND   (Netherlands)

Author keywords

Endometrial cancer; Immunohistochemistry; Lynch syndrome; Methylation analysis; Microsatellite instability; Mismatch repair

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM TUMOR; FEMALE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; METHYLATION; MISMATCH REPAIR; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING; SINGLE STRAND CONFORMATION POLYMORPHISM;

BRAZIL; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA METHYLATION; DNA MISMATCH REPAIR; DNA REPAIR; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MUTS HOMOLOG 2 PROTEIN; RISK;

EID: 77955054101     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-009-9297-x     Document Type: Article

References (31)

1. Hadley DW, Jenkins JF, Steinberg SM et al (2008) Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome. J Clin Oncol 26(6):948-954
2. Buttin BM, Powell MA, Mutch DG et al (2004) Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation. Clin Cancer Res 10(2):481-490
3. Black D, Soslow RA, Levine DA et al (2006) Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. J Clin Oncol 24(11):1745-1753
4. de la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4(10):769-780
5. Millar AL, Pal T, Madlensky L et al (1999) Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium. Hum Mol Genet 8(5):823-829
6. Vasen HF (2005) Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]. Fam Cancer 4(3):219-225
7. Arnold CN, Goel A, Blum HE et al (2005) Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis. Cancer 104(10):2035-2047
8. Lu HK, Broaddus RR (2005) Gynecologic cancers in Lynch syndrome/HNPCC. Fam Cancer 4(3):249-254
9. Modica I, Soslow RA, Black D et al (2007) Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma. Am J Surg Pathol 31(5):744-751
10. Lancaster JM, Powell CB, Kauff ND et al (2007) Society of gynecologic oncologists education committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 107(2):159-162
11. Hewitt MJ, Wood N, Quinton ND et al (2006) The detection of microsatellite instability in blind endometrial samples-a potential novel screening tool for endometrial cancer in women from hereditary nonpolyposis colorectal cancer families? Int J Gynecol Cancer 16(3):1393-1400
12. Lagerstedt Robinson K, Liu T, Vandrovcova J et al (2007) Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 99(4):291-299
13. Meyer LA, Broaddus RR, Lu KH (2009) Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control 16(1):14-22
14. Broaddus RR, Lynch HT, Chen LM et al (2006) Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. Cancer 106(1): 87-94
15. Matthews KS, Estes JM, Conner MG et al (2008) Lynch syndrome in women less than 50 years of age with endometrial cancer. Obstet Gynecol 111(5):1161-1166
16. Peltomäki P (2005) Lynch syndrome genes. Fam Cancer 4(3): 227-232
17. Kariola R, Raevaara TE, Lönnqvist KE et al (2002) Functional analysis of MSH6 mutations linked to kindreds with putative hereditary non-polyposis colorectal cancer syndrome. Hum Mol Genet 11(11):1303-1310 (Pubitemid 34555527)
18. Abdel-Rahman WM, Peltomäki P (2008) Lynch syndrome and related familial colorectal cancers. Crit Rev Oncog 14(1):1-22 (discussion 23-31)
19. Watson P, Riley B (2005) The tumor spectrum in the Lynch syndrome. Fam Cancer 4(3):245-248
20. Oliveira Ferreira F, Napoli Ferreira CC, Rossi BM et al (2004) Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: an analysis by a Brazilian hereditary colorectal cancer institutional registry. Fam Cancer 3(1):41-47
21. Geary J, Sasieni P, Houlston R et al (2008) Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer 7(2):163-172
22. Berends MJ,WuY, SijmonsRHet al (2003) Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J Clin Oncol 21(23):4364-4370
23. Zhang L (2008) Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing. J Mol Diagn 10(4):301-307
24. Iacopetta B, Hamelin R (1998) Rapid and nonisotopic SSCPbased analysis of the BAT-26 mononucleotide repeat for identification of the replication error phenotype in human cancers. Hum Mutat 12:355-360 (Pubitemid 28475614)
25. The National Comprehensive Cancer Network, Fort Washington, PA. http://www.nccn.org. Cited 6 Mar 2009
26. Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J (2007) Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. Evid Rep Technol Assess (Full Rep) (150):1-180
27. Shia J, Klimstra DS, Nafa K et al (2005) Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol 29(1):96-104
28. Shia J (2008) Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn 10(4):293-300
29. Halvarsson B, Lindblom A, Rambech E et al (2004) Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? Virchows Arch 444(2):135-141 (Pubitemid 38315290)
30. MRC-Holland, Amsterdam, The Netherlands. http://www.mrcholland.com. Cited 16 Feb 2009
31. Jeuken JW, Cornelissen SJ, Vriezen M et al (2007) MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas. Lab Invest 87(10):1055-1065